Zybroclear 100 Capsule contains Acebrophylline 100mg, a bronchodilator and mucolytic agent used primarily in the management of respiratory conditions characterized by bronchospasm and excessive mucus production. Acebrophylline acts by relaxing the smooth muscles of the airways, thereby improving airflow and facilitating easier breathing. Additionally, it exhibits anti-inflammatory properties and enhances mucociliary clearance, which helps in reducing mucus viscosity and promoting expectoration. Zybroclear 100 is indicated for the treatment of chronic obstructive pulmonary disease (COPD), asthma, bronchitis, and other obstructive airway diseases. The capsule formulation ensures convenient oral administration with predictable absorption and bioavailability. It is generally well-tolerated, but patients should be monitored for potential side effects such as gastrointestinal discomfort, headache, or allergic reactions. Caution is advised in individuals with a history of hypersensitivity to xanthine derivatives or those with cardiovascular disorders. Zybroclear 100 should be used under medical supervision, with dosage adjustments based on clinical response and patient tolerance. This medication may be used as part of a comprehensive respiratory management plan, including bronchodilators, corticosteroids, and lifestyle modifications, to optimize pulmonary function and improve quality of life in affected patients.